Profiel
Dr. Martina Diekmann is a Chief Executive Officer at Mytide Therapeutics, Inc. and a President, Chief Executive Officer & Director at vivitite LLC.
She is on the Board of Directors at vivitite LLC.
Dr. Diekmann was previously employed as a Chief Executive Officer by New England Peptide, Inc. She received her doctorate degree from the University of Bonn.
Actieve functies van Martina Diekmann
| Bedrijven | Functie | Begin |
|---|---|---|
vivitite LLC
vivitite LLC Medical SpecialtiesHealth Technology Manufactures and distributes peptides, antibodies & bio-chemicals for research and development purposes | Algemeen Directeur | 01-02-2020 |
Mytide Therapeutics, Inc.
Mytide Therapeutics, Inc. Packaged SoftwareTechnology Services Develops peptide synthesis technology | Algemeen Directeur | 30-03-2023 |
Eerdere bekende functies van Martina Diekmann
| Bedrijven | Functie | Einde |
|---|---|---|
New England Peptide, Inc.
New England Peptide, Inc. Chemicals: Major DiversifiedProcess Industries Designs and produces custom peptides and polyclonal antibodies | Algemeen Directeur | - |
Opleiding van Martina Diekmann
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Bonn
University of Bonn Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New England Peptide, Inc.
New England Peptide, Inc. Chemicals: Major DiversifiedProcess Industries Designs and produces custom peptides and polyclonal antibodies | Process Industries |
Mytide Therapeutics, Inc.
Mytide Therapeutics, Inc. Packaged SoftwareTechnology Services Develops peptide synthesis technology | Technology Services |
vivitite LLC
vivitite LLC Medical SpecialtiesHealth Technology Manufactures and distributes peptides, antibodies & bio-chemicals for research and development purposes | Health Technology |
















